Myoclonic Seizures in a Patient With Charcot-Marie-Tooth Disease

Juan Piantino, Alcy Torres

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Charcot-Marie-Tooth disease affects both motor and sensory peripheral nerves, with broad variability in its clinical and pathologic expression. The involvement of the central nervous system in this disease has been reported in the past, and on two occasions Charcot-Marie-Tooth disease was associated with myoclonic seizures. The previously reported patients with associated Charcot-Marie-Tooth disease and seizures developed a severe disease and died at a young age. This report describes a now 8-year-old male with Charcot-Marie-Tooth disease type 1A associated with myoclonic seizures and developmental delay. Genetic studies established for the first time the duplication of the PMP-22 gene in a patient with this unusual association, confirming the diagnosis. The patient was treated with carbamazepine, valproate, and lamotrigine, has been seizure-free for over 2 years, and was successfully weaned from his medications.

Original languageEnglish (US)
Pages (from-to)118-120
Number of pages3
JournalPediatric Neurology
Volume36
Issue number2
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Charcot-Marie-Tooth Disease
Seizures
Central Nervous System Diseases
Carbamazepine
Valproic Acid
Peripheral Nerves
Genes

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology

Cite this

Myoclonic Seizures in a Patient With Charcot-Marie-Tooth Disease. / Piantino, Juan; Torres, Alcy.

In: Pediatric Neurology, Vol. 36, No. 2, 02.2007, p. 118-120.

Research output: Contribution to journalArticle

@article{15643ecd153d43569ab6e5a770bd1c67,
title = "Myoclonic Seizures in a Patient With Charcot-Marie-Tooth Disease",
abstract = "Charcot-Marie-Tooth disease affects both motor and sensory peripheral nerves, with broad variability in its clinical and pathologic expression. The involvement of the central nervous system in this disease has been reported in the past, and on two occasions Charcot-Marie-Tooth disease was associated with myoclonic seizures. The previously reported patients with associated Charcot-Marie-Tooth disease and seizures developed a severe disease and died at a young age. This report describes a now 8-year-old male with Charcot-Marie-Tooth disease type 1A associated with myoclonic seizures and developmental delay. Genetic studies established for the first time the duplication of the PMP-22 gene in a patient with this unusual association, confirming the diagnosis. The patient was treated with carbamazepine, valproate, and lamotrigine, has been seizure-free for over 2 years, and was successfully weaned from his medications.",
author = "Juan Piantino and Alcy Torres",
year = "2007",
month = "2",
doi = "10.1016/j.pediatrneurol.2006.09.006",
language = "English (US)",
volume = "36",
pages = "118--120",
journal = "Pediatric Neurology",
issn = "0887-8994",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Myoclonic Seizures in a Patient With Charcot-Marie-Tooth Disease

AU - Piantino, Juan

AU - Torres, Alcy

PY - 2007/2

Y1 - 2007/2

N2 - Charcot-Marie-Tooth disease affects both motor and sensory peripheral nerves, with broad variability in its clinical and pathologic expression. The involvement of the central nervous system in this disease has been reported in the past, and on two occasions Charcot-Marie-Tooth disease was associated with myoclonic seizures. The previously reported patients with associated Charcot-Marie-Tooth disease and seizures developed a severe disease and died at a young age. This report describes a now 8-year-old male with Charcot-Marie-Tooth disease type 1A associated with myoclonic seizures and developmental delay. Genetic studies established for the first time the duplication of the PMP-22 gene in a patient with this unusual association, confirming the diagnosis. The patient was treated with carbamazepine, valproate, and lamotrigine, has been seizure-free for over 2 years, and was successfully weaned from his medications.

AB - Charcot-Marie-Tooth disease affects both motor and sensory peripheral nerves, with broad variability in its clinical and pathologic expression. The involvement of the central nervous system in this disease has been reported in the past, and on two occasions Charcot-Marie-Tooth disease was associated with myoclonic seizures. The previously reported patients with associated Charcot-Marie-Tooth disease and seizures developed a severe disease and died at a young age. This report describes a now 8-year-old male with Charcot-Marie-Tooth disease type 1A associated with myoclonic seizures and developmental delay. Genetic studies established for the first time the duplication of the PMP-22 gene in a patient with this unusual association, confirming the diagnosis. The patient was treated with carbamazepine, valproate, and lamotrigine, has been seizure-free for over 2 years, and was successfully weaned from his medications.

UR - http://www.scopus.com/inward/record.url?scp=33846606372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846606372&partnerID=8YFLogxK

U2 - 10.1016/j.pediatrneurol.2006.09.006

DO - 10.1016/j.pediatrneurol.2006.09.006

M3 - Article

VL - 36

SP - 118

EP - 120

JO - Pediatric Neurology

JF - Pediatric Neurology

SN - 0887-8994

IS - 2

ER -